AZD7270, AZD7270, Lokelma 5 g powder for oral suspension, AZD7270, Lokelma 5 g powder for oral suspension
D9481C00001
Phase 3 small_molecule active
Quick answer
AZD7270, AZD7270, Lokelma 5 g powder for oral suspension, AZD7270, Lokelma 5 g powder for oral suspension for Hyperkalaemia is a Phase 3 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Hyperkalaemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active